AATec Medical vs Spero Therapeutics

AATec Medical logo

AATec Medical

Pioneering biotech solutions for inflammatory disorders, viral infections, and rare diseases with recombinant alpha-1 antitrypsin (AAT)

2-10 employees

VS
Spero Therapeutics logo

Spero Therapeutics

Clinical-stage biotech company focused on rare diseases and diseases with high unmet need

44 employees · est. 2013 · Cambridge, United States

Spero Therapeutics is the larger of the two.

Side-by-Side Comparison

AATec Medical Spero Therapeutics
Founded
Not tracked yet 2013
Headquarters
Not tracked yet Cambridge, United States
Employees
2-10 44 larger
Industry
Biotechnology, Health Care Biotechnology, Pharmaceutical
Funding Stage
Seed IPO
Total Funding
$2.70M $374.60M
Funding Rounds
1 12
Services
Not tracked yet Development of Oral Carbapenem Antibiotics, Drug Pipeline for Rare and MDR Infections, Clinical Trial Execution, Partnership Development
Target Customers
Not tracked yet Patients with Complicated Urinary Tract Infections, Patients with Pyelonephritis, Healthcare Providers, Pharmaceutical Collaborators
Taxonomy
BiotechRecombinantAlpha-1 AntitrypsinInflammatory DisordersViral InfectionsRare Diseases +3 BiopharmaceuticalClinical-stageBiotech CompanyBacterial InfectionsMulti-drug ResistantRare Diseases +9
Website
aatec-medical.com sperotherapeutics.com
AATec Medical logo

About AATec Medical

AATec Medical is a pioneering biotech firm that focuses on developing solutions for inflammatory disorders, viral infections, and rare diseases using recombinant alpha-1 antitrypsin (AAT). The company's mission is to leverage the potential of AAT to address unmet medical needs in biotechnology and h...

Spero Therapeutics logo

About Spero Therapeutics

Spero Therapeutics, founded in 2013 and headquartered in the United States, is a multi-asset, clinical-stage biotech company specializing in treatments for multidrug-resistant bacterial infections and rare diseases. With a strong focus on addressing antibiotic resistance, the company is carving out...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches AATec Medical and Spero Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when AATec Medical or Spero Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

AATec Medical was with 2-10 employees. AATec Medical is a pioneering biotech firm that focuses on developing solutions for inflammatory disorders, viral infections, and rare diseases using recombinant alpha-1 antitrypsin (AAT). The company. Spero Therapeutics was founded in 2013, based in Cambridge, United States, with 44 employees. Spero Therapeutics, founded in 2013 and headquartered in the United States, is a multi-asset, clinical-stage biotech company specializing in treatments for multidrug-resistant bacterial infections and.
AATec Medical has raised $2.70M and Spero Therapeutics $374.60M. Latest stage: AATec Medical Seed, Spero Therapeutics IPO.
Both work in Biotechnology and list rare diseases and drug development among their focus areas.

Compare AATec Medical with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AATec Medical on 21 Jun 2024, and Spero Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes